Avanos Medical, Inc. (AVNS) Reports In-Line Q2 EPS, Updates Guidance
Avanos Medical, Inc. (NYSE: AVNS) reported Q2 EPS of $0.28, in-line with the analyst estimate of $0.28. Revenue for the ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)